BiotechTube
Home/Moleac/Herve D’Allens
HD

Herve D’Allens

Medical and Marketing Advisor

Moleac

Therapeutic Areas

NeurologyStrokeTraumatic Brain InjurySpinal Cord InjuryAlzheimer's Disease

Moleac Pipeline

DrugIndicationPhase
MLC901 (NeuroAiD)Post‑stroke, Traumatic Brain Injury, Cognitive DeclinePhase 2/3
MLC1501Post‑stroke motor recoveryPhase 2
ANDROMEDAModerate Traumatic Brain InjuryPhase 2
SAMURAIMild Traumatic Brain Injury – Cognitive FunctionPhase 2
MAESTOSOPost‑stroke motor deficitsPhase 2

Leadership Team at Moleac

DP
David Picard
CEO
RG
Robert Gan
Senior Medical Advisor
CY
Claire Yim
Vice President, Commercial Development
NZ
Nianmin Zhou
Alliances in China
JS
Jonathan Seow
Vice President, Chief Financial Officer
View full Moleac profile